Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 35 36 37 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Mitsubishi Chemical–Covagen: FynomAb technology, 201210– collab + license €4m upfront + €108.25m milestones + royalties per target pair with TRL 2012-10-17
Nextval–Bruker Corp: mass spectrometer, 201210– collab using ultrafleXtreme system + Compass s/w with Nextval’s MassInsight technology 2012-10-16
Thermo Fisher–Immundiagnostik: MS-based proteomic assays, 201210– collab developm product integration ImmunoTube technology with LC-MS/MS 2012-10-16
Merck (US)–Strüngmann Group: virostatic agents, 201210– license excl ww HCMV portfolio incl letermovir €110m upfront + €332.5m + royalties fr AiCuris 2012-10-15
Addex–SEVERAL: investment, 201210 private placement $10.3m gross proceeds 918k new ordinary shares CHF10.5/share to institutional investors 2012-10-12
JeNaCell–High-Tech Gründerfonds: investment, 201210 seed financing totalling €700k from HTGF + STIFT 2012-10-12
JeNaCell–SEVERAL: investment, 201210 seed financing €700k from HTGF + STIFT 2012-10-12
JeNaCell–Thuringia (govt): investment, 201210 seed financing totalling €700k from HTGF + STIFT 2012-10-12
Analytik Jena–Russian Academy of Sciences: analytical instruments, 201210 collab new Analytik Jena Competence Center located at Zelinsky Institute 2012-10-09
InterLab (RU)–Analytik Jena: analytical instruments, 201210 existent most imporant sales partner in Russia + partner for Competence Center in Moscow 2012-10-09
November–R-Biopharm: investment, 201210 acquisition €na 100% of Progen Biotechnik GmbH out of bankrupt November AG i IN 2012-10-09
Affimed–Aeris Capital: investment, 201210 financing round Series D totalling €15.5m incl investor Aeris Capital 2012-10-08
Affimed–BioMedPartners: investment, 201210 financing round Series D totalling €15.5m incl investor BioMedInvest 2012-10-08
Affimed–Life Sciences Partners: investment, 201210 financing round Series D totalling €15.5m incl investor LSP 2012-10-08
Affimed–Novo Group: investment, 201210 financing round Series D totalling €15.5m incl investor Novo Nordisk A/S 2012-10-08
Affimed–OrbiMed: investment, 201210 financing round Series D totalling €15.5m incl investor Orbimed 2012-10-08
Affimed–SEVERAL: investment, 201210 financing round Series D €15.5m 2012-10-08
COSMOS project–EU (Govt): grant, 201210– FP7 funding €2m for COordination Of Standards in MetabOlomicS 2012-10-08
Creathor Venture–SEVERAL: investment, 201210 final closing €80m Creathor Venture Fund III incl investor EIF 2012-10-05
Sweden (govt)–Bruker Corp: mass spectrometer, 201210 supply existent maXis impact incl use of new PesticideScreener solution at NFA 2012-10-05
Tecan–BioNTech: peptide microarray technology, 201210– collab co-promotion JPT peptide arrays with Tecan microarray handling devices 2012-10-02
AMP-Therapeutics–Germany (govt): grant, 201210–201409 BMBF Innovative Therapies grant totalling €1.8m to AMP + Univ Leipzig 2012-10-01
Bayer–Evotec: drug discovery services, 201210– collab 5y €12m upfront + up to €580m milestones developm of 3 drug candidates to treat endometriosis 2012-10-01
Definiens–Cipio Partners: investment, 201210 private financing round totalling €10m incl returning co-investor Cipio 2012-10-01
Definiens–Gilde Investment: investment, 201210 private financing round totalling €10m incl new + lead investor Gilde Healthcare Partners 2012-10-01
Definiens–SEVERAL: investment, 201210 private financing round €10m led by new investor Gilde Healthcare Partners 2012-10-01
Definiens–TVM: investment, 201210 private financing round totalling €10m incl returning co-investor TVM 2012-10-01
GeneWake–Germany (govt): grant, 201210– 3-year BMBF grant €450k to develop pharmacodiagnostic test for colon cancer 2012-10-01
Piqur Therapeutics–SEVERAL: investment, 201210 seed funding from private investors + KTI 2012-10-01
STATegra project–EU (govt): grant, 201210–201509 FP7 funding €6m out of total project cost of €7.85m 2012-10-01
Leco–Genedata: mass spectrometry software, 201209 collab existent product integration Expressionist MSX s/w with High Resolution TOFMS 2012-09-25
Ayoxxa–High-Tech Gründerfonds: investment, 201209 financing round Series A totalling €2.6m incl co-investor HTGF 2012-09-20
Ayoxxa–North Rhine-Westphalia (govt): investment, 201209 financing round Series A totalling €2.6m incl co-investor NRW.BANK 2012-09-20
Ayoxxa–PERSON: investment, 201209 financing round Series A totalling €2.6m incl co-investor Gregor Siebenkotten 2012-09-20
Ayoxxa–PERSON: investment, 201209 financing round Series A totalling €2.6m incl co-investor Rainer Christine 2012-09-20
Ayoxxa–SEVERAL: investment, 201209 financing round Series A €2.6m led by Wellington Partners 2012-09-20
Ayoxxa–Wellington Partners: investment, 201209 financing round Series A totalling €2.6m incl lead investor Wellington Partners 2012-09-20
Genalyte–Scienion: print/spotting technology, 201209– co-marketing of sciFlexarrayer S5 + offering of custom spotting services by Genalyte 2012-09-19
Pasteuria Bioscience–Syngenta: investment, 201209 acquisition $86m + $27m milestones ANNOUNCED 2012-09-19
CureVac–Hopp Group: investment, 201209 financing round Series D €80m from dievini Hopp BioTech Holding 2012-09-18
IRIS International–Danaher: investment, 201209–201210 acquisition $338m cash tender offer $19.5/share to be integrated in Beckman Coulter Dx business 2012-09-17
Bruker Corp–Russian Academy of Sciences: ParaCell technology, 201209 collab existent integration of ParaCell in new solariX XR FTMS system 2012-09-16
Teva–Bayer: investment, 201209–201301 acquisition $60m upfront + $85m milestones of US animal health business of Teva by Bayer HealthCare 2012-09-14
Lepu Medical–Qiagen: ESEQuant Lateral Flow System, 201209– supply OEM marketed as LEPU Quant-Gold w cardiac markers in China by Lepu 2012-09-13
Bruker Corp–Univ Washington: Skyline software, 201207 collab integration of Skyline s/w with maXis mass spectrometers MacCoss Lab of Biological MS 2012-09-10
Scienion–Maine Manufacturing: protein microarray technology, 201209– non-excl ww distribution of FAST Slide product line by Scienion 2012-09-10
Thermo Fisher–Protein Metrics: proteomic s/w tools, 201207– license Byonic database search s/w for integration w Proteome Discoverer + Preview s/w 2012-09-10
Boehringer–ETH Zürich: diabetes + obesity research, 201209– collab translational research Institutes of Mol Health Science + Food Nutrition Health 2012-09-06
Sigma-Aldrich–Danaher: mass spectrometry reagents, 201209– distribution ww of iChemistry Solutions of AB Sciex 2012-09-06
F2G Ltd–SEVERAL: investment, 201209 financing round $30m incl new investors Advent Life Sciences + Novartis Bioventures 2012-09-05
High-Tech Gründerfonds–SAP: investment, 201209 investment in High-Tech Gründerfonds II by SAP Ventures 2012-09-04
Merck (DE)–Quartz Bio: bioinformatics, 201209– supply service approx €2m with next 2 to 3 years to Merck Serono 2012-09-03
Molegro–CLC bio: investment, 201209 acquisition €na by CLC bio A/S 2012-09-03
Deutsches Epigenom-Projekt DEEP–Germany (govt): grant, 201209–201708 BMBF grant €16m for 5 years 2012-09-01
Deutsches Epigenom-Projekt DEEP–Qiagen: epigenomics, 201209–201708 Qiagen GmbH is a project partner 2012-09-01
Merck (DE)–Symphogen: antibody cancer drug, 201209–201501 ww license to Sym004 RIGHTS RETURNED 1/15 2012-09-01
SuppreMol–SEVERAL: investment, 201209 financing round Series D 1st closing €6.5m 2012-09-01
Implandata–EnjoyVenture: investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW 2012-08-24
Implandata–Germany (govt): investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW 2012-08-24
Implandata–Peppermint: investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW 2012-08-24
Implandata–SEVERAL: investment, 201208 financing round Series A 2nd closing €1.6m Peppermint + EnjoyVenture + ERP Startfonds of KfW 2012-08-24
Univ Maryland–Bruker Corp: mass spectrometer, 201208 supply existent Bruker AmaZon X Ion Trap MS at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Bruker Corp: mass spectrometer, 201208 supply existent Bruker Autoflex Speed MALDI TOF/TOF system at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Thermo Fisher: mass spectrometer, 201208 supply existent Q-Exactive MS w Dionex UltiMate 3000 UHPLC at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Thermo Fisher: mass spectrometer, 201208 supply existent TSQ Quantum Ultra w UltiMate 3000 UHPLC at MS Facility at School of Pharmacy 2012-08-24
Biochrom (DE)–Merck (DE): investment, 201208–201211 acquisition €na of Biochrom AG 2012-08-22
NeuroAllianz project–Germany (govt): grant, 201208– €15m BioPharma grant from BMBF 2012-08-22
Univ Rostock–Leco: mass spectrometer, 201208 supply Citius LC-HRT to Joint Mass Spectrometry Centre 2012-08-22
Univ Rostock–Leco: mass spectrometer, 201208 supply Pegasus GC-HRT to Joint Mass Spectrometry Centre 2012-08-22
Aperio–Danaher: investment, 201208 acquisition by Leica Biosystems 2012-08-21
Artes Biotechnology–Peschek Analytic Consulting: protein analysis, 201208– collab adding of PACs analytical services to Artes product portfolio 2012-08-21
BBG/Braun Group–Axa: investment, 201208 acquisition of Riemser Arzneimittel AG from Braun family + minority shareolders incl TVM Capital 2012-08-21
Penrith Corp–Siemens: investment, 201208– acquisition of substantially all assets by Siemens Healthcare ANNOUNCED 2012-08-21
Analis–Anagnostics: hybcell technology, 201208– distribution of Anagnostics’ products in Belgium + Luxembourg by Analis SA 2012-08-17
Analytik Jena–SEVERAL: credit, 201208– promissory note loan €30m replacing among other things existent €12m loan 2012-08-14
Avir Green Hills–NONE: investment, 201208–201308 bankruptcy 2012-08-12
Northwestern Univ–Keck Foundation: grant, 201208 grant $1m to Neil Kelleher for developm of new hybrid mass spectrometer w Thermo Fisher 2012-08-10
Thermo Fisher–Northwestern Univ: mass spectrometry, 201208– developm of new hybrid mass spectrometer with Prof Neil Kelleher 2012-08-10
Cempra–Curetis: Unyvero platform, 201208– collab r+d use of Unyvero system + Pneumonia test in P3 study of solithromycin 2012-08-09
EDMA–General Electric: in vitro diagnostics, 201208– membership PAA Laboratories becomes new member of EDMA 2012-08-09
Thermo Fisher–Martin Bauer Group: mass spectrometry, 201208 collab developm pesticide analysis mass spec method for herbal products PhytoLab GmbH 2012-08-09
Ecotech–Ionicon: mass spectrometer, 201208– distribution + support of Ioncion PTR-MS instruments by Ecotech Pty Ltd in Australia 2012-08-07
Ecotech–Ionicon: mass spectrometer, 201208– distribution + support of Ioncion PTR-MS instruments by Ecotech Pty Ltd in New Zealand 2012-08-07
Evonik–BRAIN: industrial biotechnology, 201208– collaboration €na developm of microorganisms to add properties to surfaces 2012-08-07
Aenova–BC Partners: investment, 201208 acquisition €500m of Aenova from majority shareholder Bridgepoint + two minority shareholders 2012-08-06
Novartis–Univ Pennsylvania: T-cell immunotherapy, 201208– collab excl ww RnD alliance to develop CAR cancer therapies 2012-08-06
Proteros–Bavaria (govt): investment, 201208 3rd financing round totalling €5m incl lead investor BayBG 2012-08-06
Proteros–BCNP Consultants: public relations, 201208 service existent by BCNP Consultants GmbH 2012-08-06
Proteros–SEVERAL: investment, 201208 3rd financing round €5m led by BayBG + incl two new investors 2012-08-06
Lonza–Univ Kyoto: stem cell technology, 201208– ww non-excl lisense to iPSC patent portfolio of iPS Acadamia Japan Inc 2012-08-02
Paragon Bioservices–Cevec: CAP technology, 201208– license to CAP + CAP-T cell expression systems for contract production of rec proteins + antibodies 2012-08-02
BlueGenics project–EU (govt): grant, 201208–201607 funding €6m out of total project cost of €8.45m 2012-08-01
AutoBio project–Germany (govt): grant, 201207–2015 BMBF grant for 3 years for programme with total volume of €3.7m 2012-07-31
Helicos–Qiagen: sequencing technology, 201207 license non-excl to 7 US patents for $1.6m from Intelligent Bio-Systems 2012-07-30
Prexton Therapeutics–Merck (DE): investment, 201207 seed financing €2.1m in spin-off of Merck Serono Geneva managed by Merck Serono Ventures 2012-07-30
General Electric–iBio: rec protein production, 201207– collab expansion €na global alliance iBioLaunch techn w CMB + ww marketing by GE Healthcare 2012-07-26
Rentschler–MHH: gene therapy vector system, 201207 license for commercialisation of vector system developed by Prof Baum et al 2012-07-25
Antisense Pharma–MC Services: public relations, 201207 service existent for Antisense Pharma GmbH 2012-07-24
Evonik–BioAmber: catalysts, 201207– collab long-term developm + manufacturing of catalysts to use bio-based succinic acid 2012-07-24
SuppreMol–Germany (govt): grant, 201207– BMBF grant €1.37m for early development of SM401 within m4 cluster initiative 2012-07-24
next pagenext page 1 2 3 ... 35 36 37 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top